Segmentectomy for c-T1N0M0 non-small cell lung cancer

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Pulmonary Medicine

Background:

• Segmentectomy for lung cancer is debated but gaining acceptance for early stages (cT1aN0M0).
• Current literature and data are reviewed to address key surgical and oncological aspects.

Purpose of the Study:

• To critically evaluate the role and outcomes of segmentectomy in treating non-small cell lung cancer.
• To discuss critical surgical elements, including lymph node dissection and intersegmental plane management.
• To explore future directions and expectations for segmentectomy, including major clinical trials.

Main Methods:

• Literature review of segmentectomy for lung cancer.
• Presentation and discussion of clinical data pertaining to segmentectomy outcomes.
• Analysis of specific surgical techniques and patient selection criteria.

Main Results:

• Segmentectomy shows promising results for specific early-stage lung cancers, but long-term prognosis requires further evaluation.
• Local recurrence rates and optimal lymph node dissection areas are key considerations.
• Postoperative pulmonary function is generally preserved, but completion lobectomy may be indicated in certain cases.

Conclusions:

• Segmentectomy is a viable option for select early-stage non-small cell lung cancer patients.
• Further research, including randomized controlled trials like JCOG0802, is crucial to solidify its role.
• Refinement of surgical techniques and patient selection will optimize outcomes for segmentectomy.